The Efficacy and Safety of First-Line Single-Inhaler Triple versus Dual Therapy in Controller-Naïve and Symptomatic Adults with Asthma: A Preliminary Retrospective Cohort Study.

J Asthma Allergy · 2023 · PMC9985402 · PMID 36879847

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

The different general assessments of daytime and nighttime conditions may be significant using the daytime and nighttime VAS in patients with uncontrolled asthma. 28 Thus, early relief of nocturnal symptoms may improve general conditions faster than daytime symptom relief. 28 Our study showed that SITT efficacy appeared faster than SIDT efficacy for nighttime VAS and ACT scores but not for daytime VAS.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.